Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Cosmetic Science
  4. Fast Track Articles
  5. Fast Track Article
image of Drug-Device Combinations in Dermatology: Integrating Pharmaceuticals with Advanced Cosmetic Technologies

Abstract

Background

A paradigm shift is brought about by the combination of medicines with cutting-edge medical technology, which improves patient outcomes, effectiveness, and accuracy. The review dives into applications such as anti-aging therapy, nanotechnology, and acne treatment while also examining obstacles, traditional procedures, and current breakthroughs. It highlights the difficulties with patient adherence, safety, and regulatory barriers while projecting a future where genetics, biosensors, and artificial intelligence will power tailored therapies. Emphasis is placed on the potential for global dermatological health, imagining a time when drug-device combos would alter skincare globally.

Objectives

This study aims to provide a comprehensive overview of the current landscape of drug-device combinations in dermatology and advancement in drug-device combinations for dermatological therapy.

Methods

A literature search was performed on PubMed and Google Scholar using the following key terms” Dermatology,” “Cosmetic technologies,” “Dermatopharmacology,” “Beauty Perception,” and “Skincare.”

Result

The assessment of the safety and effectiveness profiles of various drug-device combinations, considering long-term effects, adverse events, patient satisfaction, and clinical results. This includes an examination of the fundamental processes by which pharmaceuticals and cutting-edge cosmetic technologies work together to produce therapeutic outcomes like improved drug delivery, targeted therapy, and synergistic effects.

Conclusion

In conclusion, drug-device combinations offer a viable way to improve therapeutic outcomes and elevate patient care in dermatology by fusing pharmaceuticals with cutting-edge cosmetic technology. Our analysis focuses on the wide range of combinations that are currently available, as well as their effectiveness, safety profiles, and underlying mechanisms of action. Even though there has been a lot of development, issues, including patient variability, technical constraints, and regulatory barriers, still exist.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cosci/10.2174/0126667797340276241219105142
2024-12-27
2025-01-29

  • From This Site

    /content/journals/cosci/10.2174/0126667797340276241219105142
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Donalisio M. Leone F. Civra A. Spagnolo R. Ozer O. Lembo D. Cavalli R. Acyclovir-loaded chitosan nanospheres from nano-emulsion templating for the topical treatment of herpesviruses infections. Pharmaceutics 2018 10 2 46 10.3390/pharmaceutics10020046 29642603
    [Google Scholar]
  2. Choi S.H. Wang Y. Conti D.S. Raney S.G. Delvadia R. Leboeuf A.A. Witzmann K. Generic drug device combination products: Regulatory and scientific considerations. Int. J. Pharm. 2018 544 2 443 454 10.1016/j.ijpharm.2017.11.038 29170118
    [Google Scholar]
  3. Cohen M. Austin E. Masub N. Kurtti A. George C. Jagdeo J. Home-based devices in dermatology: A systematic review of safety and efficacy. Arch. Dermatol. Res. 2022 314 3 239 246 10.1007/s00403‑021‑02231‑0 33938981
    [Google Scholar]
  4. Mavranezouli I. Daly C.H. Welton N.J. Deshpande S. Berg L. Bromham N. Arnold S. Phillippo D.M. Wilcock J. Xu J. Ravenscroft J.C. Wood D. Rafiq M. Fou L. Dworzynski K. Healy E. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br. J. Dermatol. 2022 187 5 639 649 10.1111/bjd.21739 35789996
    [Google Scholar]
  5. Lo A. Lovell K.K. Greenzaid J.D. Oscherwitz M.E. Feldman S.R. Adherence to treatment in dermatology: Literature review. JEADV Clin. Pract. 2024 3 2 401 418 10.1002/jvc2.379
    [Google Scholar]
  6. Labadie J.G. Ibrahim S.A. Worley B. Kang B.Y. Rakita U. Rigali S. Arndt K.A. Bernstein E. Brauer J.A. Chandra S. Didwania A. DiGiorgio C. Donelan M. Dover J.S. Galadari H. Geronemus R.G. Goldman M.P. Haedersdal M. Hruza G. Ibrahimi O.A. Kauvar A. Kelly K.M. Krakowski A.C. Miest R. Orringer J.S. Ozog D.M. Ross E.V. Shumaker P.R. Sobanko J.F. Suozzi K. Taylor M.B. Teng J.M.C. Uebelhoer N.S. Waibel J. Wanner M. Ratchev I. Christensen R.E. Poon E. Miller C.H. Alam M. Evidence-based clinical practice guidelines for laser-assisted drug delivery. JAMA Dermatol. 2022 158 10 1193 1201 10.1001/jamadermatol.2022.3234 35976634
    [Google Scholar]
  7. Alkilani A.Z. Nasereddin J. Hamed R. Nimrawi S. Hussein G. Abo-Zour H. Donnelly R.F. Beneath the skin: A review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics 2022 14 6 1152 10.3390/pharmaceutics14061152 35745725
    [Google Scholar]
  8. Gorzelanny C. Mess C. Schneider S.W. Huck V. Brandner J.M. Skin barriers in dermal drug delivery: Which barriers have to be overcome and how can we measure them? Pharmaceutics 2020 12 7 684 10.3390/pharmaceutics12070684 32698388
    [Google Scholar]
  9. Yang D. Chen M. Sun Y. Jin Y. Lu C. Pan X. Quan G. Wu C. Microneedle-mediated transdermal drug delivery for treating diverse skin diseases. Acta Biomater. 2021 121 119 133 10.1016/j.actbio.2020.12.004 33285323
    [Google Scholar]
  10. Parhi R. Mandru A. Enhancement of skin permeability with thermal ablation techniques: Concept to commercial products. Drug Deliv. Transl. Res. 2021 11 3 817 841 10.1007/s13346‑020‑00823‑3 32696221
    [Google Scholar]
  11. Akhtar N. Singh V. Yusuf M. Khan R. A. 2020 Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomedical Engineering 65 3 243 272 10.1515/bmt‑2019‑0019
    [Google Scholar]
  12. Kar A. Ahamad N. Dewani M. Awasthi L. Patil R. Banerjee R. Wearable and implantable devices for drug delivery: Applications and challenges. Biomaterials 2022 283 121435 10.1016/j.biomaterials.2022.121435 35227964
    [Google Scholar]
  13. Yu Y.Q. Yang X. Wu X.F. Fan Y.B. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: Novel strategies for effective transdermal applications. Front. Bioeng. Biotechnol. 2021 9 646554 10.3389/fbioe.2021.646554 33855015
    [Google Scholar]
  14. Van Gheluwe L. Chourpa I. Gaigne C. Munnier E. Polymer-based smart drug delivery systems for skin application and demonstration of stimuli-responsiveness. Polymers 2021 13 8 1285 10.3390/polym13081285 33920816
    [Google Scholar]
  15. Bakshi P. Vora D. Hemmady K. Banga A.K. Iontophoretic skin delivery systems: Success and failures. Int. J. Pharm. 2020 586 119584 10.1016/j.ijpharm.2020.119584 32603836
    [Google Scholar]
  16. Kováčik A. Kopečná M. Vávrová K. Permeation enhancers in transdermal drug delivery: Benefits and limitations. Expert Opin. Drug Deliv. 2020 17 2 145 155 10.1080/17425247.2020.1713087 31910342
    [Google Scholar]
  17. Matter M. Probst S. Läuchli S. Herrmann I. Uniting drug and delivery: Metal oxide hybrid nanotherapeutics for skin wound care. Pharmaceutics 2020 12 8 780 10.3390/pharmaceutics12080780 32824470
    [Google Scholar]
  18. Yang H. Fierro F. So M. Yoon D.J. Nguyen A.V. Gallegos A. Bagood M.D. Rojo-Castro T. Alex A. Stewart H. Chigbrow M. Dasu M.R. Peavy T.R. Soulika A.M. Nolta J.A. Isseroff R.R. Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. Stem Cells Transl. Med. 2020 9 11 1353 1364 10.1002/sctm.19‑0380 32720751
    [Google Scholar]
  19. Pleguezuelos-Beltrán P. Gálvez-Martín P. Nieto-García D. Marchal J.A. López-Ruiz E. Advances in spray products for skin regeneration. Bioact. Mater. 2022 16 187 203 10.1016/j.bioactmat.2022.02.023 35386328
    [Google Scholar]
  20. Guillot A.J. Martínez-Navarrete M. Garrigues T.M. Melero A. Skin drug delivery using lipid vesicles: A starting guideline for their development. J. Control. Release 2023 355 624 654 10.1016/j.jconrel.2023.02.006 36775245
    [Google Scholar]
  21. Ramadon D. McCrudden M.T.C. Courtenay A.J. Donnelly R.F. Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug Deliv. Transl. Res. 2022 12 4 758 791 10.1007/s13346‑021‑00909‑6 33474709
    [Google Scholar]
  22. Qu F. Geng R. Liu Y. Zhu J. Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics 2022 12 7 3372 3406 10.7150/thno.69999 35547773
    [Google Scholar]
  23. Manikkath J. Subramony J.A. Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems. Adv. Drug Deliv. Rev. 2021 179 113997 10.1016/j.addr.2021.113997 34634396
    [Google Scholar]
  24. Research I. Research I. Global dermatology devices market forecast. 2023 Available from https://www.inkwoodresearch.com/reports/dermatology-devices-market/
  25. Nastiti C. Ponto T. Abd E. Grice J. Benson H. Roberts M. Topical nano and microemulsions for skin delivery. Pharmaceutics 2017 9 4 37 10.3390/pharmaceutics9040037 28934172
    [Google Scholar]
  26. Pandey P.C. Shukla S. Skoog S.A. Boehm R.D. Narayan R.J. Current advancements in transdermal biosensing and targeted drug delivery. Sensors 2019 19 5 1028 10.3390/s19051028 30823435
    [Google Scholar]
  27. Massella D. Argenziano M. Ferri A. Guan J. Giraud S. Cavalli R. Barresi A.A. Salaün F. Bio-functional textiles: Combining pharmaceutical nanocarriers with fibrous materials for innovative dermatological therapies. Pharmaceutics 2019 11 8 403 10.3390/pharmaceutics11080403 31405229
    [Google Scholar]
  28. Nagula R.L. Wairkar S. Recent advances in topical delivery of flavonoids: A review. J. Control. Release 2019 296 January 190 201 10.1016/j.jconrel.2019.01.029 30682442
    [Google Scholar]
  29. Nath P.A. Nivrutti P.R Drug Penetration Enhancement Techniques in Transdermal Drug Delivery System: A Review J. Pharm. Res. Int. 2021 33 19
    [Google Scholar]
  30. Sabri A.H. Ogilvie J. Abdulhamid K. Shpadaruk V. McKenna J. Segal J. Scurr D.J. Marlow M. Expanding the applications of microneedles in dermatology. Eur. J. Pharm. Biopharm. 2019 140 April 121 140 10.1016/j.ejpb.2019.05.001 31059780
    [Google Scholar]
  31. Alkilani A. McCrudden M.T. Donnelly R. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015 7 4 438 470 10.3390/pharmaceutics7040438 26506371
    [Google Scholar]
  32. Budhathoki U. Gartoulla K. Shakya S. Formulation and evaluation of transdermal patches of atenolol. Indones. J. Pharm. 2016 27 4 196 202 10.14499/indonesianjpharm27iss4pp196
    [Google Scholar]
  33. Baldwin D. Gold S. Study results in focus: Assessing the clinical efficacy of Epiduo 2017 Available from : https://assets.bmctoday.net/practicaldermatology/pdfs/0817_insert.pdf
  34. Tan M. Xu Y. Gao Z. Yuan T. Liu Q. Yang R. Zhang B. Peng L. Recent advances in intelligent wearable medical devices integrating biosensing and drug delivery. Adv. Mater. 2022 34 27 2108491 10.1002/adma.202108491 35008128
    [Google Scholar]
  35. Expanding personalized, data-driven dermatology: leveraging digital health technology and machine learning to improve patient outcomes JID Innovations 2022 2 3
    [Google Scholar]
  36. BBI K2 IPL DPL beauty machine for skin rejuvenation and hair remove Available fromhttps://www.bbilaser.com/ipl-machine/bbi-k2-ipl-dpl-beauty-mchine-for-skin.html
  37. Schaller M. Dirschka T. Lonne-Rahm S.B. Micali G. Stein Gold L.F. Tan J. Del Rosso J. The importance of assessing burning and stinging when managing Rosacea: A review. Acta Derm. Venereol. 2021 101 10 adv00584 10.2340/actadv.v101.356 34643244
    [Google Scholar]
  38. Gastaminza G. Azofra J. Nunez-Cordoba J.M. Baeza M.L. Echechipía S. Gaig P. García B.E. Labrador-Horrillo M. Sala-Cunill A. Brescó M.S. Beristain A. Quiñones D. Donado C.D. Zubeldia J.M. Ferrer M. Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial. J. Allergy Clin. Immunol. Pract. 2019 7 5 1599 1609.e1 10.1016/j.jaip.2018.12.025 30654196
    [Google Scholar]
  39. Overchuk M. Weersink R.A. Wilson B.C. Zheng G. Photodynamic and photothermal therapies: Synergy opportunities for nanomedicine. ACS Nano 2023 17 9 7979 8003 10.1021/acsnano.3c00891 37129253
    [Google Scholar]
  40. Potaś J. Szymańska E. Winnicka K. Challenges in developing of chitosan – Based polyelectrolyte complexes as a platform for mucosal and skin drug delivery. Eur. Polym. J. 2020 140 110020 10.1016/j.eurpolymj.2020.110020
    [Google Scholar]
  41. Răileanu M. Borlan R. Campu A. Janosi L. Turcu I. Focsan M. Bacalum M. No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection. Int. J. Pharm. 2023 642 123169 10.1016/j.ijpharm.2023.123169 37356506
    [Google Scholar]
  42. Tian J. Song X. Wang Y. Cheng M. Lu S. Xu W. Gao G. Sun L. Tang Z. Wang M. Zhang X. Regulatory perspectives of combination products. Bioact. Mater. 2022 10 492 503 10.1016/j.bioactmat.2021.09.002 34901562
    [Google Scholar]
  43. Ferraris C. Rimicci C. Garelli S. Ugazio E. Battaglia L. Nanosystems in cosmetic products: A brief overview of functional, market, regulatory and safety concerns. Pharmaceutics 2021 13 9 1408 10.3390/pharmaceutics13091408 34575484
    [Google Scholar]
  44. Lee J.S. Kim J. Cui B. Kim S.K. Cho S.A. An S. Cho S.W. Hybrid skin chips for toxicological evaluation of chemical drugs and cosmetic compounds. Lab Chip 2022 22 2 343 353 10.1039/D1LC00550B 34904990
    [Google Scholar]
  45. Reis M.E. Bettencourt A. Ribeiro H.M. The regulatory challenges of innovative customized combination products. Front. Med. (Lausanne) 2022 9 821094 10.3389/fmed.2022.821094 35935795
    [Google Scholar]
  46. Dsouza L. Ghate V.M. Lewis S.A. Derma rollers in therapy: The transition from cosmetics to transdermal drug delivery. Biomed. Microdevices 2020 22 4 77 10.1007/s10544‑020‑00530‑3 33104926
    [Google Scholar]
  47. Carlomagno F. Roveda G. Michelotti A. Ruggeri F. Tursi F. Anti-Skin-Aging effect of a treatment with a cosmetic product and a food supplement based on a new hyaluronan: A randomized clinical study in healthy women. Cosmetics 2022 9 3 54 10.3390/cosmetics9030054
    [Google Scholar]
  48. Su Z. Luo F. Pei X. Zhang F. Xing S. Wang G. Final citation of the “Regulations on the supervision and administration of cosmetics” and new prospectives of cosmetic science in China. Cosmetics 2020 7 4 98 10.3390/cosmetics7040098
    [Google Scholar]
  49. Kumar P. Mahor A. Chaudhary V. Sharma S. Nanotechnology: Current Developments, applications and patents for non-invasive topical cosmetics and dermatological therapeutic delivery. Drug Deliv. Lett. 2024 14 3 179 197 10.2174/0122103031285090240418091630
    [Google Scholar]
  50. DeGrazio F. Paskiet D. Injectable combination product development: Facilitating Risk-based assessments for efficiency and patient centric outcomes. J. Pharm. Sci. 2020 109 7 2101 2115 10.1016/j.xphs.2020.03.020 32272133
    [Google Scholar]
  51. Park K.Y. López Gehrke I. Combined multilevel anti‐aging strategies and practical applications of dermocosmetics in aesthetic procedures. J. Eur. Acad. Dermatol. Venereol. 2024 38 S4 Suppl. 4 23 35 10.1111/jdv.19975 38881448
    [Google Scholar]
  52. Cassuto D. Bellia G. Schiraldi C. An overview of soft tissue fillers for cosmetic dermatology: From filling to regenerative medicine. Clin. Cosmet. Investig. Dermatol. 2021 14 1857 1866 10.2147/CCID.S276676 34992400
    [Google Scholar]
  53. Zargaran D. Zoller F.E. Zargaran A. Mosahebi A. Complications of facial cosmetic botulinum toxin A injection: analysis of the UK Medicines & Healthcare Products Regulatory Agency registry and literature review. J. Plast. Reconstr. Aesthet. Surg. 2022 75 1 392 401 10.1016/j.bjps.2021.05.074 34456155
    [Google Scholar]
  54. Calvo F. Gómez J.M. Ricardez-Sandoval L. Alvarez O. Integrated design of emulsified cosmetic products: A review. Chem. Eng. Res. Des. 2020 161 279 303 10.1016/j.cherd.2020.07.014
    [Google Scholar]
  55. Salager J.L. Antón R. Bullón J. Forgiarini A. Marquez R. How to use the normalized hydrophilic-lipophilic deviation (HLDN) concept for the formulation of equilibrated and emulsified surfactant-oil-water systems for cosmetics and pharmaceutical products. Cosmetics 2020 7 3 57 10.3390/cosmetics7030057
    [Google Scholar]
  56. Microneedles: A new way to deliver vaccines. J. Pharm 2023
    [Google Scholar]
  57. Barthe M. Bavoux C. Finot F. Mouche I. Cuceu-Petrenci C. Forreryd A. Chérouvrier Hansson A. Johansson H. Lemkine G.F. Thénot J.P. Osman-Ponchet H. Safety testing of cosmetic products: Overview of established methods and new approach methodologies (NAMs). Cosmetics 2021 8 2 50 10.3390/cosmetics8020050
    [Google Scholar]
  58. Al-Nimry S. Dayah A.A. Hasan I. Daghmash R. Cosmetic, biomedical and pharmaceutical applications of fish gelatin/hydrolysates. Mar. Drugs 2021 19 3 145 10.3390/md19030145 33800149
    [Google Scholar]
  59. Petersburg dermatology experiences operational benefits by using the modmed® dermatology suite. 2022 Available from https://www.modmed.com/resources/blog/st-petersburg-dermatology-experiences-operational-benefits-by-using-the-modmed-dermatology-suite
  60. Khesina Z.B. Iartsev S.D. Revelsky A.I. Buryak A.K. Microextraction by packed sorbent optimized by statistical design of experiment as an approach to increase the sensitivity and selectivity of HPLC-UV determination of parabens in cosmetics. J. Pharm. Biomed. Anal. 2021 195 113843 10.1016/j.jpba.2020.113843 33358620
    [Google Scholar]
  61. Banerjee P. Ulker O.C. Combinative ex vivo studies and in silico models ProTox-II for investigating the toxicity of chemicals used mainly in cosmetic products. Toxicol. Mech. Methods 2022 32 7 542 548 10.1080/15376516.2022.2053623 35287538
    [Google Scholar]
  62. Dini I. Laneri S. The new challenge of green cosmetics: Natural food ingredients for cosmetic formulations. Molecules 2021 26 13 3921 10.3390/molecules26133921 34206931
    [Google Scholar]
  63. Saha T. Hoque M.E. Mahbub T. Biopolymers for sustainable packaging in food, cosmetics, and pharmaceuticals. Elsevier 2020 197 214 10.1016/B978‑0‑12‑819661‑8.00013‑5
    [Google Scholar]
  64. Das B. Kumar B. Begum W. Bhattarai A. Mondal M.H. Saha B. Comprehensive review on applications of surfactants in vaccine formulation, therapeutic and cosmetic pharmacy and prevention of pulmonary failure due to COVID-19. Chem. Africa 2022 5 3 459 480 10.1007/s42250‑022‑00345‑0
    [Google Scholar]
  65. Ahmad A. Ahsan H. Lipid-based formulations in cosmeceuticals and biopharmaceuticals. Biomed. Dermatol. 2020 4 1 12 10.1186/s41702‑020‑00062‑9
    [Google Scholar]
  66. Sotiropoulou G. Zingkou E. Pampalakis G. Redirecting drug repositioning to discover innovative cosmeceuticals. Exp. Dermatol. 2021 30 5 628 644 10.1111/exd.14299 33544970
    [Google Scholar]
  67. Bilal M. Mehmood S. Iqbal H.M.N. The beast of beauty: Environmental and health concerns of toxic components in cosmetics. Cosmetics 2020 7 1 13 10.3390/cosmetics7010013
    [Google Scholar]
  68. Alhasso B. Ghori M.U. Conway B.R. Systematic review on the effectiveness of essential and carrier oils as skin penetration enhancers in pharmaceutical formulations. Sci. Pharm. 2022 90 1 14 10.3390/scipharm90010014
    [Google Scholar]
  69. Chen J. Ren H. Zhou P. Zheng S. Du B. Liu X. Xiao F. Microneedle-mediated drug delivery for cutaneous diseases. Front. Bioeng. Biotechnol. 2022 10 1032041 10.3389/fbioe.2022.1032041 36324904
    [Google Scholar]
  70. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 2001 14 2 101 114 10.1016/S0928‑0987(01)00167‑1 11500256
    [Google Scholar]
  71. Gidde N.D. Karande K.A. Jadhav S.S. Mistry R.S. Mhetre A. Joshi S.D. Microsponge. An Overview. 2021 23 11 671 682
    [Google Scholar]
  72. Vitthal P. Anuradha S. Review on microsponges drug delivery system Int. j. res. anal. rev. 2020 7 1 961 974
    [Google Scholar]
  73. Tiwari A. Tiwari V. Palaria B. Kumar M. Kaushik D. Microsponges: A breakthrough tool in pharmaceutical research. Future J. Pharm. Sci. 2022 8 1 31 10.1186/s43094‑022‑00421‑9
    [Google Scholar]
  74. Gusai T. Dhavalkumar M. Soniwala M. Dudhat K. Vasoya J. Chavda J. Formulation and optimization of microsponge-loaded emulgel to improve the transdermal application of acyclovir—a DOE based approach. Drug Deliv. Transl. Res. 2021 11 5 2009 2029 10.1007/s13346‑020‑00862‑w 33159290
    [Google Scholar]
  75. Boen M. Brownell J. Patel P. Tsoukas M.M. The role of photodynamic therapy in acne: An evidence-based review. Am. J. Clin. Dermatol. 2017 18 3 311 321 10.1007/s40257‑017‑0255‑3 28276005
    [Google Scholar]
  76. Kemény L. Szabó K. Innate and adaptive immunity in acne vulgaris Acne. Updates. Clin. Dermatol 2021 149 157 10.1007/978‑3‑030‑68996‑4_14
    [Google Scholar]
  77. Halder J. Gupta S. Kumari R. Gupta G.D. Rai V.K. Microneedle array: Applications, recent advances, and clinical pertinence in transdermal drug delivery. J. Pharm. Innov. 2021 16 3 558 565 10.1007/s12247‑020‑09460‑2 32837607
    [Google Scholar]
  78. Atiyeh B.S. Abou Ghanem O. Chahine F. Microneedling: Percutaneous Collagen Induction (PCI) therapy for management of scars and photoaged skin—scientific evidence and review of the literature. Aesthetic Plast. Surg. 2021 45 1 296 308 10.1007/s00266‑020‑01927‑4 32875437
    [Google Scholar]
  79. Khetpal S. Ghosh D. Roostaeian J. Innovations in skin and soft tissue aging—a systematic literature review and market analysis of therapeutics and associated outcomes. Aesthetic Plast. Surg. 2023 47 4 1609 1622 10.1007/s00266‑023‑03322‑1 37154849
    [Google Scholar]
  80. Sivasubramanian M. Chuang Y.C. Lo L.W. Evolution of nanoparticle-mediated photodynamic therapy: From superficial to deep-seated cancers. Molecules 2019 24 3 520 10.3390/molecules24030520 30709030
    [Google Scholar]
  81. Liu Z. Xie Z. Li W. Wu X. Jiang X. Li G. Cao L. Zhang D. Wang Q. Xue P. Zhang H. Photodynamic immunotherapy of cancers based on nanotechnology: Recent advances and future challenges. J. Nanobiotechnology 2021 19 1 160 10.1186/s12951‑021‑00903‑7 34051801
    [Google Scholar]
  82. Chota A. George B.P. Abrahamse H. Recent advances in green metallic nanoparticles for enhanced drug delivery in photodynamic therapy: A therapeutic approach. Int. J. Mol. Sci. 2023 24 5 4808 10.3390/ijms24054808 36902238
    [Google Scholar]
  83. Khadka B. Lee B. Kim K.T. Drug delivery systems for personal healthcare by smart wearable patch system. Biomolecules 2023 13 6 929 10.3390/biom13060929 37371509
    [Google Scholar]
  84. Raikar A.S. Kumar P. Raikar G.V.S. Somnache S.N. Advances and challenges in IoT-based smart drug delivery systems: A comprehensive review. Appl. Syst. Innov. 2023 6 4 62 10.3390/asi6040062
    [Google Scholar]
  85. Joo H. Lee Y. Kim J. Yoo J.S. Yoo S. Kim S. Arya A.K. Kim S. Choi S.H. Lu N. Lee H.S. Kim S. Lee S.T. Kim D.H. Soft implantable drug delivery device integrated wirelessly with wearable devices to treat fatal seizures. Sci. Adv. 2021 7 1 eabd4639 10.1126/sciadv.abd4639 33523849
    [Google Scholar]
  86. Reddy M.A. Pradhan B.K. Qureshi Di. Pal S.K. Pal K. 2020 Internet-of-things-enabled dual-channel iontophoretic drug delivery system for elderly patient medication management. J. Med. Devices 14 1 1 12 10.1115/1.4045933
    [Google Scholar]
  87. Kumoluyi R. Khanolkar A. Risk management in drug-device combination product development. Ther. Innov. Regul. Sci. 2022 56 5 685 688 10.1007/s43441‑022‑00425‑w 35753035
    [Google Scholar]
  88. Eichenfield L.F. McFalda W. Brabec B. Siegfried E. Kwong P. McBride M. Rieger J. Willson C. Davidson M. Burnett P. Safety and efficacy of VP-102, a proprietary, drug-device combination product containing cantharidin, 0.7% (w/v), in children and adults with Molluscum Contagiosum. JAMA Dermatol. 2020 156 12 1315 1323 10.1001/jamadermatol.2020.3238 32965495
    [Google Scholar]
  89. Planz V. Lehr C.M. Windbergs M. In vitro models for evaluating safety and efficacy of novel technologies for skin drug delivery. J. Control. Release 2016 242 89 104 10.1016/j.jconrel.2016.09.002 27612408
    [Google Scholar]
  90. Oliveira R. Almeida I.F. Patient-centric design of topical dermatological medicines. Pharmaceuticals 2023 16 4 617 10.3390/ph16040617 37111373
    [Google Scholar]
  91. Araviiskaia E. Layton A.M. Estebaranz J.L.L. Ochsendorf F. Micali G. The synergy between pharmacological regimens and dermocosmetics and its impact on adherence in acne treatment. Dermatol. Res. Pract. 2022 2022 1 10 10.1155/2022/3644720 35982914
    [Google Scholar]
  92. Vallejos X. Wu C. Digital medicine: Innovative drug-device combination as new measure of medication adherence. J. Pharm. Technol. 2017 33 4 137 139 10.1177/8755122517704212 34860983
    [Google Scholar]
  93. Latoz C. Larkin L. Huynh-Ba K. Stability considerations for drug-device combination products-21 CFR part 4 update. AAPS Open 2023 9 1 10 10.1186/s41120‑023‑00078‑5
    [Google Scholar]
  94. Messick S. Saggu M. Ríos Quiroz A. Particles in biopharmaceuticals: Causes, characterization, and strategy Advances in the Pharmaceutical Sciences Series Springer 2020 251 264 10.1007/978‑3‑030‑31415‑6_11
    [Google Scholar]
  95. Masterson F. Factors that facilitate regulatory approval for drug-device combination products in the European Union and United States of America: A mixed method study of industry views. Ther. Innov. Regul. Sci. 2018 52 4 489 498 10.1177/2168479017735142 29714544
    [Google Scholar]
  96. Pourkavoos N. Unique risks, benefits, and challenges of developing drug-drug combination products in a pharmaceutical industrial setting. Comb. Prod. Therap 2012 2 1 2 10.1007/s13556‑012‑0002‑2
    [Google Scholar]
  97. Auriemma G. Tommasino C. Falcone G. Esposito T. Sardo C. Aquino R.P. Additive manufacturing strategies for personalized drug delivery systems and medical devices: Fused filament fabrication and semi solid extrusion. Molecules 2022 27 9 2784 10.3390/molecules27092784 35566146
    [Google Scholar]
  98. Vora L.K. Gholap A.D. Jetha K. Thakur R.R.S. Solanki H.K. Chavda V.P. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics 2023 15 7 1916 10.3390/pharmaceutics15071916
    [Google Scholar]
/content/journals/cosci/10.2174/0126667797340276241219105142
Loading
Drug-Device Combinations in Dermatology: Integrating Pharmaceuticals with Advanced Cosmetic Technologies
Bentham Science Publishers ; https://doi.org/10.2174/0126667797340276241219105142
/content/journals/cosci/10.2174/0126667797340276241219105142
/content/journals/cosci/10.2174/0126667797340276241219105142
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: dermatology ; drug delivery ; skin care ; Nanotechnology

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test